A randomized multicenter phase II trial of mecapegfilgrastim single administration versus granulocyte colony-stimulating growth factor on treating chemotherapy-induced neutropenia in breast cancer patients

BACKGROUND: This study aimed to evaluate the efficacy and safety of mecapegfilgrastim (HHPG-19K) with different doses compared to granulocyte colony-stimulating growth factor (G-CSF) in treating chemotherapy-induced neutropenia in breast cancer patients. METHODS: A total of 182 breast cancer patient...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Transl Med
Main Authors: Wang, Tao, Wu, Biao, Hu, Xichun, Liu, Jinping, Zhang, Tao, Li, Funian, Sun, Bing, Cai, Li, Li, Xinzheng, Chen, Zhiyue, Yang, Qing, Jiang, Zefei
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6545320/
https://ncbi.nlm.nih.gov/pubmed/31205914
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2019.04.10
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados